Lincoln International’s Global Healthcare Group Announces Record Year

Lincoln International remains one of the most active healthcare M&A advisors in 2021

Lincoln International’s global healthcare mergers and acquisitions (M&A) activity in 2021 eclipsed that of 2020 led by the firm’s growing sector capabilities and strong appetite for deals. In 2021, we completed transactions with or on behalf of some of the largest and most well-known names in healthcare private equity. Lincoln’s reputation for advising on, executing and closing high-quality assignments across healthcare services, life sciences, pharma outsourcing, medical products and healthcare information technology (IT) continues to strengthen. Lincoln is one of the only investment banks with dedicated, senior healthcare bankers covering markets across the Americas, Europe and Asia.

Summary

  • Lincoln International's global Healthcare Group celebrates record results in 2021.

Select Notable 2021 Healthcare Transactions

Related Perspectives

Mint | Hospital investors line up over $2 bn in exits as covid-19 recedes

Originally published by Mint on May 16, 2022. Lincoln International’s Gaurav Marathe, Managing Director and CEO India, discusses hospital chain performance during the pandemic and future considerations for investors. Click here… Read More

The Corner Series Podcast | Investor Interest: What’s Happening in Home Healthcare?

Barry Freeman, Managing Director in Lincoln’s Healthcare Group, joins Geoff Cockrell, host of the The Corner Series podcast, to discuss trends and investing opportunities in home health, hospice and palliative… Read More

M&A Activity Remains Strong for Companies Supporting Employer-Sponsored Health Benefits

Employer-sponsored, self-funded medical plans have grown in popularity since the implementation of ERISA in the 1970s and now cover nearly two-thirds of all employees and one-third of all Americans. Medical… Read More

Scrip | What Does 2022 Hold For Biopharma?

Originally published by SCRIP on February 8 , 2022. James West, Director in Lincoln’s Healthcare Group shares that there has been increased private equity firm’s interest in the Biopharma space and… Read More

Meet Our Senior Team